| Lisa Johnson Kirk, DO | |
|
318 Richland West Circle, Suite A, Waco, TX 76712-7919 | |
| (254) 776-8008 | |
| (254) 776-6892 |
| Full Name | Lisa Johnson Kirk |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 318 Richland West Circle, Waco, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578562146 | NPI | - | NPPES |
| 092305403 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | K3775 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Health Center | Waco, TX | Hospital |
| Baylor Scott & White Medical Center Hillcrest | Waco, TX | Hospital |
| Entity Name | Waco Functional Medicine, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093016826 PECOS PAC ID: 0244416162 Enrollment ID: O20110510000819 |
News Archive
A study published in The Journal of Pain showed that just 2 of 3 accredited physical therapy (PT) schools surveyed believe their students receive adequate education in pain management.
GlycoVaxyn AG, a leader in the development of conjugate vaccines, today announced that it will host its Second Annual Science Day to discuss challenges and opportunities in vaccine development on June 16-17, 2011, in Cannes, France.
Most of the state regulators allowing insurers to renew canceled plans, as proposed by President Barack Obama, are led by Republican governors who have opposed the law. Of the eight refusing to carry out the policy, six are in Democrat-led states that have embraced the law and who fear the extensions would undermine it.
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
› Verified 1 days ago
| Entity Name | Happy Health And Wellness Of America Pa Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770344889 PECOS PAC ID: 5092150714 Enrollment ID: O20240304001413 |
News Archive
A study published in The Journal of Pain showed that just 2 of 3 accredited physical therapy (PT) schools surveyed believe their students receive adequate education in pain management.
GlycoVaxyn AG, a leader in the development of conjugate vaccines, today announced that it will host its Second Annual Science Day to discuss challenges and opportunities in vaccine development on June 16-17, 2011, in Cannes, France.
Most of the state regulators allowing insurers to renew canceled plans, as proposed by President Barack Obama, are led by Republican governors who have opposed the law. Of the eight refusing to carry out the policy, six are in Democrat-led states that have embraced the law and who fear the extensions would undermine it.
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
› Verified 1 days ago
| Entity Name | Happy Health And Wellness Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629844014 PECOS PAC ID: 5698111946 Enrollment ID: O20240309000371 |
News Archive
A study published in The Journal of Pain showed that just 2 of 3 accredited physical therapy (PT) schools surveyed believe their students receive adequate education in pain management.
GlycoVaxyn AG, a leader in the development of conjugate vaccines, today announced that it will host its Second Annual Science Day to discuss challenges and opportunities in vaccine development on June 16-17, 2011, in Cannes, France.
Most of the state regulators allowing insurers to renew canceled plans, as proposed by President Barack Obama, are led by Republican governors who have opposed the law. Of the eight refusing to carry out the policy, six are in Democrat-led states that have embraced the law and who fear the extensions would undermine it.
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
› Verified 1 days ago
| Entity Name | Gtg Enterprises Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588240782 PECOS PAC ID: 9032555834 Enrollment ID: O20240315000574 |
News Archive
A study published in The Journal of Pain showed that just 2 of 3 accredited physical therapy (PT) schools surveyed believe their students receive adequate education in pain management.
GlycoVaxyn AG, a leader in the development of conjugate vaccines, today announced that it will host its Second Annual Science Day to discuss challenges and opportunities in vaccine development on June 16-17, 2011, in Cannes, France.
Most of the state regulators allowing insurers to renew canceled plans, as proposed by President Barack Obama, are led by Republican governors who have opposed the law. Of the eight refusing to carry out the policy, six are in Democrat-led states that have embraced the law and who fear the extensions would undermine it.
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Johnson Kirk, DO 318 Richland West Circle, Suite A, Waco, TX 76712-7919 Ph: (254) 776-8008 | Lisa Johnson Kirk, DO 318 Richland West Circle, Suite A, Waco, TX 76712-7919 Ph: (254) 776-8008 |
News Archive
A study published in The Journal of Pain showed that just 2 of 3 accredited physical therapy (PT) schools surveyed believe their students receive adequate education in pain management.
GlycoVaxyn AG, a leader in the development of conjugate vaccines, today announced that it will host its Second Annual Science Day to discuss challenges and opportunities in vaccine development on June 16-17, 2011, in Cannes, France.
Most of the state regulators allowing insurers to renew canceled plans, as proposed by President Barack Obama, are led by Republican governors who have opposed the law. Of the eight refusing to carry out the policy, six are in Democrat-led states that have embraced the law and who fear the extensions would undermine it.
The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.
› Verified 1 days ago
Allison L Hulme, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-750-8200 Fax: 254-750-8326 | |
Timothy Martindale, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7104 New Sanger Rd, Waco, TX 76712 Phone: 254-741-1113 Fax: 254-741-1342 | |
Dr. Brian Douglas Bull, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 851 North Loop 340, Waco, TX 76705 Phone: 254-202-7500 Fax: 254-202-7599 | |
Dr. Matthew R Porter, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 W. State Hwy 6, Waco, TX 76712 Phone: 254-313-6700 Fax: 254-313-4531 | |
Lianda Mirella Martinez, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Franklin Ave, Suite B-c, Waco, TX 76701 Phone: 254-537-6590 Fax: 254-537-6599 | |
Dr. Aman A Shah, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hillcrest Medical Blvd, Waco, TX 76712 Phone: 254-202-2000 | |
Dr. Rita L Haws, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Providence Dr, Waco, TX 76707 Phone: 254-313-4200 Fax: 254-313-4549 |